ESR1 and breast cancer: Using chromatin immunoprecipitation (ChIP) combined with tiled DNA microarrays targeting chromosomes 20 and 21, Carroll et al. discovered the broad-ranging requirement for FOXA1 to facilitate ER-binding and estrogen-induced transcriptional programs in a luminal breast cancer cell line [41].